Abstract
Objective: Kidney stones are crystalline concrete that often develops inside the kidneys. Urinary tract problems are getting worse and worse for human health. The risk of end-stage kidney failure has been associated with increase the level of a new biomarker (like xanthine oxidase) to assess severity of kidney injury. Methods: The eighty patients, who attended the government clinics in Yarmouk Teaching Hospital, and the forty healthy people were used as a control group. Colorimetric assays were used to assess serum xanthine oxidase (XO) and other biochemical parameters. Using an enzyme-linked immunosorbent assay was determined. Results: The mean serum XO activity (8.8525 IU/L) was significantly greater than the corresponding values for the controls (6.5825 IU/L). Patients with kidney stones showed abnormal activity of uric acid levels in 78.33% of cases, while XO activity showed highly sensitive (70%) and high specificity (79%). XO has been found to be an excellent biomarker for detecting damage of the kidney in people suffering from kidney stones.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call